Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Ulcerative Colitis

In brief

The principal aim of this study is to evaluate the safety and tolerability of RO7049665 in participants with active ulcerative colitis (UC).

Key facts

Study ID
NCT03943550
Run by
Hoffmann-La Roche
People needed
45
Starts
2019-05-13
Expected to finish
2021-07-22
Last updated by the study team
2024-02-15

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.